COO US EQUITY Health Care Health Care Supplies CIK: 711404

Cooper Companies (The) (COO) Quant Factor Diagnostic & Fair Value Model

Cooper Companies (The) (Ticker: COO) is listed in the Health Care sector (Health Care Supplies). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$61.21

-81.53% Latest Close (2026-10-23)

Market Cap: $11.64B

P/E Ratio: 6.8

Momentum Strength 3M / 12M

-84.21%

1M: -81.82% 12M: -76.32%

Quality (ROE) Point-in-Time

+20.79%

Trailing Return on Equity

Technical Trend RSI 14

66.7

SMA50: $250.10 SMA200: $336.04

Valuation Multiplier Trailing

6.8

Deep Value (Under 15x P/E)

📊 Valuation & Multi-Factor Diagnostic

Deep Value (Under 15x P/E)

COO trades at an attractive earnings multiple of 6.8x, significantly lower than the broader S&P 500 average.

Compare in Screener

⚡ Benchmark Factor Strategy

S&P 500 Momentum Alpha Strategy

This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

Strategy Marketplace Open Strategy →

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线整理 (MA20/50) Piotroski F-Score: 5/9 (Moderate Financial Health)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 711404 · 10-K 年报 / 10-Q 季报

Form	Period End	Filing Timestamp (Point-in-Time)	Revenue	Net Income	Operating CF	EPS (Diluted)
10-Q	2026-07-31	2026-09-09	-	$432.80M	$785.40M	$2.24
10-Q	2026-04-30	2026-09-09	-	-$77.90M	$443.70M	$-0.40
10-Q	2026-01-31	2026-09-09	-	$130.80M	$260.90M	$0.66
10-Q	2025-10-31	2026-09-09	-	-	-	-
10-Q	2025-07-31	2026-09-09	-	$98.30M	$548.20M	$0.49
10-Q	2025-04-30	2026-09-09	-	$87.70M	$286.80M	$0.44
10-Q	2025-01-31	2026-09-09	-	$104.30M	$190.60M	$0.52
10-K	2025-10-31	2025-12-05	-	$374.90M	$796.10M	$1.87

💡 Methodology & Frequently Asked Questions

Key reference details regarding Cooper Companies (The) (COO) valuation multiples, momentum factors, and point-in-time filing conventions.

How should COO's current valuation multiple be interpreted? ↓

COO trades at a trailing P/E of 6.8x within the Health Care sector (deep value (under 15x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.

What are COO's key momentum and technical factor indicators? ↓

As of the latest close, COO shows a 1-month return of -81.82%, 3-month return of -84.21%, and 12-month return of -76.32%, with a 14-day RSI of 66.7. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.

What is Point-in-Time (PIT) financial data and why does it matter for COO? ↓

Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.

How can COO be incorporated into systematic factor models? ↓

COO can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.